《对公共利益科学中心的评价》

  • 来源专题:食物与营养
  • 编译者: 潘淑春
  • 发布时间:2005-03-25
  • The Center for Science in the Public Interest (CSPI) is filing these comments on proposed changes to FDA’s nutrient content and health claims regulations.1 These comments supplement those filed by CSPI on March 20, 1996 and address issues that have arisen with the advent of the Consumer Health Information for Better Nutrition Initiative.
  • 原文来源:http://www.cspinet.org/new/pdf/reopening1995_comment.pdf
相关报告
  • 《公共利益科学中心》

    • 来源专题:食物与营养
    • 编译者:潘淑春
    • 发布时间:2004-12-25
    • has been a strong advocate for nutrition and health, food safety, alcohol policy, and sound science. Its award-winning newsletter, Nutrition Action Healthletter, is the largest-circulation health newsletter in North America, providing reliable information on nutrition and health.
  • 《公共利益科学中心请求FDA采纳GAO关于功能食品的建议》

    • 来源专题:食物与营养
    • 编译者:潘淑春
    • 发布时间:2005-03-26
    • The undersigned submits this petition under Sections 402(a), 403(a), and 701(a) of the Federal Food, Drug and Cosmetic Act (FDCA) to request that the Commissioner of the Food and Drug Administration (FDA): Develop and promulgate regulations or other guidance for industry on the safetyrelated information required on labels for functional foods; Develop an enhanced system to record and analyze reports of health problems associated with functional foods; Issue regulations to clearly establish the nature and extent of evidence companies need to adequately support structure/function claims; Require manufacturers of functional foods to provide notification of the use of novel ingredients to the FDA prior to marketing; Require manufacturers of food products making structure/function claims on labels or on labeling to provide notification to the FDA within 30 days after marketing begins; Require all foods with structure/function claims to carry the disclaimer currently required on dietary supplements that make such claims; and Establish an advisory committee to reevaluate the current labeling approaches for foods with novel ingredients to determine whether the istinctions between structure/function claims and health claims are understood by consumers and identify other changes needed to improve consumer understanding of health-related 1 GAO/RCED-00156 (July 2000) [hereinafter GAO Report]. 2 Id. at 4. 3 Id. at 5. The GAO further recommended that the FDA clarify the boundary between conventional foods, including functional foods and dietary supplements, particularly the circumstances under which dietary supplements may be marketed in food form. The GAO explained that the failure to have a clear boundary means that “unsafe products could come to market because companies did not develop a sufficient level of evidence on their safety.” While acknowledging that the FDA has been attempting to do this on a case-by-case basis, e.g. in its letters to Benecol and Hains, the GAO concludes that the FDA needs to clarify this boundary through regulations or guidance. Id. at 25-26. 2 claims.